(6R)-4-(5-methoxy-1H-indole-2-carbonyl)-1-[(3-methoxyphenyl)methyl]-6-(phenylmethoxymethyl)piperazin-2-one
C30H31N3O5 — CID 122600606
Data last refreshed: (MolForge compound catalog, from PubChem)
About (6R)-4-(5-methoxy-1H-indole-2-carbonyl)-1-[(3-methoxyphenyl)methyl]-6-(phenylmethoxymethyl)piperazin-2-one
(6R)-4-(5-methoxy-1H-indole-2-carbonyl)-1-[(3-methoxyphenyl)methyl]-6-(phenylmethoxymethyl)piperazin-2-one (PubChem CID 122600606) has the molecular formula C30H31N3O5 and a molecular weight of 513.59 g/mol. Its IUPAC name is (6R)-4-(5-methoxy-1H-indole-2-carbonyl)-1-[(3-methoxyphenyl)methyl]-6-(phenylmethoxymethyl)piperazin-2-one.
Molecular Properties
| Compound Name | (6R)-4-(5-methoxy-1H-indole-2-carbonyl)-1-[(3-methoxyphenyl)methyl]-6-(phenylmethoxymethyl)piperazin-2-one |
|---|---|
| PubChem CID | 122600606 |
| Molecular Formula | C30H31N3O5 |
| Molecular Weight | 513.59 g/mol |
| Exact Mass | 513.23 |
| IUPAC Name | (6R)-4-(5-methoxy-1H-indole-2-carbonyl)-1-[(3-methoxyphenyl)methyl]-6-(phenylmethoxymethyl)piperazin-2-one |
| SMILES | COc1cccc(CN2C(=O)CN(C(=O)c3cc4cc(OC)ccc4[nH]3)C[C@@H]2COCc2ccccc2)c1 |
| InChI | InChI=1S/C30H31N3O5/c1-36-25-10-6-9-22(13-25)16-33-24(20-38-19-21-7-4-3-5-8-21)17-32(18-29(33)34)30(35)28-15-23-14-26(37-2)11-12-27(23)31-28/h3-15,24,31H,16-20H2,1-2H3/t24-/m1/s1 |
| InChIKey | VXRXCAYUGXEBRJ-XMMPIXPASA-N |
| XLogP | 4.26 |
| TPSA | 84.10 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 513.59 |
| LogP ≤ 5 | 4.26 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122600606 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.